Dana N, Dabiri A, Najafi M, Rahimi A, Ishaghi S, Shariati L
Bioeng Transl Med. 2025; 10(2):e10716.
PMID: 40060757
PMC: 11883117.
DOI: 10.1002/btm2.10716.
Grigore I, Rajagopal A, Chow J, Stone T, Salmena L
Sci Rep. 2024; 14(1):27493.
PMID: 39528571
PMC: 11555236.
DOI: 10.1038/s41598-024-78337-y.
Haseeb M, Khan I, Kartal Z, Mahfooz S, Hatiboglu M
Int J Mol Sci. 2024; 25(20).
PMID: 39457052
PMC: 11509082.
DOI: 10.3390/ijms252011271.
Garofalo S, DAlessandro G, Limatola C
Adv Neurobiol. 2024; 37:513-527.
PMID: 39207710
DOI: 10.1007/978-3-031-55529-9_28.
Woo A, Sontheimer H
Front Mol Med. 2024; 3:1198021.
PMID: 39086689
PMC: 11285605.
DOI: 10.3389/fmmed.2023.1198021.
ID2-ETS2 axis regulates the transcriptional acquisition of pro-tumoral microglia phenotype in glioma.
Vazquez-Cabrera G, Skandik M, Roncier N, Real Oualit F, Cruz De Los Santos M, Baleviciute A
Cell Death Dis. 2024; 15(7):512.
PMID: 39019900
PMC: 11255298.
DOI: 10.1038/s41419-024-06903-3.
CAR-T Cells Therapy in Glioblastoma: A Systematic Review on Molecular Targets and Treatment Strategies.
Agosti E, Garaba A, Antonietti S, Ius T, Fontanella M, Zeppieri M
Int J Mol Sci. 2024; 25(13).
PMID: 39000281
PMC: 11241811.
DOI: 10.3390/ijms25137174.
Tumor associated microglia/macrophages utilize GPNMB to promote tumor growth and alter immune cell infiltration in glioma.
Yalcin F, Haneke H, Efe I, Kuhrt L, Motta E, Nickl B
Acta Neuropathol Commun. 2024; 12(1):50.
PMID: 38566120
PMC: 10985997.
DOI: 10.1186/s40478-024-01754-7.
Morphological differentiation of peritumoral brain zone microglia.
Salas-Gallardo G, Lorea-Hernandez J, Robles-Gomez A, Del Campo C, Pena-Ortega F
PLoS One. 2024; 19(3):e0297576.
PMID: 38451958
PMC: 10919594.
DOI: 10.1371/journal.pone.0297576.
Pediatric low-grade glioma models: advances and ongoing challenges.
Yvone G, Breunig J
Front Oncol. 2024; 13:1346949.
PMID: 38318325
PMC: 10839015.
DOI: 10.3389/fonc.2023.1346949.
The TGF-β Family in Glioblastoma.
Golan-Cancela I, Caja L
Int J Mol Sci. 2024; 25(2).
PMID: 38256140
PMC: 10816220.
DOI: 10.3390/ijms25021067.
Glioma-Immune Cell Crosstalk in Tumor Progression.
Elguindy M, Young J, Mondal I, Lu R, Ho W
Cancers (Basel). 2024; 16(2).
PMID: 38254796
PMC: 10813573.
DOI: 10.3390/cancers16020308.
A Prediction Model for Deciphering Intratumoral Heterogeneity Derived from the Microglia/Macrophages of Glioma Using Non-Invasive Radiogenomics.
Zhu Y, Song Z, Wang Z
Brain Sci. 2023; 13(12).
PMID: 38137116
PMC: 10742081.
DOI: 10.3390/brainsci13121667.
Glioblastoma Immunotherapy: A Systematic Review of the Present Strategies and Prospects for Advancements.
Agosti E, Zeppieri M, De Maria L, Tedeschi C, Fontanella M, Panciani P
Int J Mol Sci. 2023; 24(20).
PMID: 37894718
PMC: 10606063.
DOI: 10.3390/ijms242015037.
Defining super-enhancers by highly ranked histone H4 multi-acetylation levels identifies transcription factors associated with glioblastoma stem-like properties.
Das N, Chang J, Hon C, Thomas Kelly S, Ito S, Lizio M
BMC Genomics. 2023; 24(1):574.
PMID: 37759202
PMC: 10523799.
DOI: 10.1186/s12864-023-09659-w.
Intra- and Intertumoral Microglia/Macrophage Infiltration and Their Associated Molecular Signature Is Highly Variable in Canine Oligodendroglioma: A Preliminary Evaluation.
Toedebusch R, Wei N, Simafranca K, Furth-Jacobus J, Brust-Mascher I, Stewart S
Vet Sci. 2023; 10(6).
PMID: 37368789
PMC: 10303632.
DOI: 10.3390/vetsci10060403.
Brain macrophage development, diversity and dysregulation in health and disease.
Silvin A, Qian J, Ginhoux F
Cell Mol Immunol. 2023; 20(11):1277-1289.
PMID: 37365324
PMC: 10616292.
DOI: 10.1038/s41423-023-01053-6.
Tumor Niches: Perspectives for Targeted Therapies in Glioblastoma.
Srivastava R, Dodda M, Zou H, Li X, Hu B
Antioxid Redox Signal. 2023; 39(13-15):904-922.
PMID: 37166370
PMC: 10654996.
DOI: 10.1089/ars.2022.0187.
Glioblastoma Microenvironment and Invasiveness: New Insights and Therapeutic Targets.
Erices J, Bizama C, Niechi I, Uribe D, Rosales A, Fabres K
Int J Mol Sci. 2023; 24(8).
PMID: 37108208
PMC: 10139189.
DOI: 10.3390/ijms24087047.
The Chemokine Receptor CCR1 Mediates Microglia Stimulated Glioma Invasion.
Zeren N, Afzal Z, Morgan S, Marshall G, Uppiliappan M, Merritt J
Int J Mol Sci. 2023; 24(6).
PMID: 36982211
PMC: 10049042.
DOI: 10.3390/ijms24065136.